These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15931815)

  • 1. Expression of p53 protein and primary tumour volume in patients with nasopharyngeal carcinoma.
    Chen MK; Lee HS; Chang JH; Chang CC
    J Otolaryngol; 2004 Oct; 33(5):304-7. PubMed ID: 15931815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
    Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
    Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary tumour volume delineation in nasopharyngeal carcinoma and correlation with 1997 AJCC tumour stage classification.
    Chang CC; Chen MK; Liu MT; Wen YS; Wu HK; Chang TH; Wu LJ; Lin SY; Lin JP
    J Otolaryngol; 2001 Aug; 30(4):231-4. PubMed ID: 11771035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of primary tumour volumes in early T-stage nasopharyngeal carcinoma.
    Chang CC; Chen MK; Liu MT; Wu HK; Hwang KL
    J Otolaryngol; 2003 Apr; 32(2):87-92. PubMed ID: 12866592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary tumour volume: important predictor of outcome for T3- and T4-staged nasopharyngeal carcinoma.
    Chen MK; Lee HS; Chang CC
    J Otolaryngol; 2004 Aug; 33(4):254-7. PubMed ID: 15903207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long Noncoding RNA Highly Upregulated in Liver Cancer Activates p53-p21 Pathway and Promotes Nasopharyngeal Carcinoma Cell Growth.
    Jiang X; Liu W
    DNA Cell Biol; 2017 Jul; 36(7):596-602. PubMed ID: 28445086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of p53 and neoplastic cell proliferation in undifferentiated nasopharyngeal carcinoma.
    Taweevisit M
    Southeast Asian J Trop Med Public Health; 2007 Jan; 38(1):136-40. PubMed ID: 17539259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on expression and relationship between proliferating cell nuclear antigen and p53 oncoprotein in nasopharyngeal carcinoma].
    Cheng Q; Wei J; Huang X
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Jul; 19(14):643-5. PubMed ID: 16248462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the correlation between the expression of protein p53 at stage III nasopharyngeal carcinoma and its biological behavior, prognosis, p53 gene mutation and the expression of LMP-1].
    Xu S; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2001 Dec; 30(6):456-9. PubMed ID: 11866991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasopharyngeal carcinoma: relationship between 18F-FDG PET-CT maximum standardized uptake value, metabolic tumour volume and total lesion glycolysis and TNM classification.
    Chan WK; Mak HK; Huang B; Yeung DW; Kwong DL; Khong PL
    Nucl Med Commun; 2010 Mar; 31(3):206-10. PubMed ID: 19966594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasopharyngeal carcinoma volume measurements determined with computed tomography: study of intraobserver and interobserver variability.
    Chang CC; Chen MK; Wu HK; Liu MT
    J Otolaryngol; 2002 Dec; 31(6):361-5. PubMed ID: 12593548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?
    Crook T; Nicholls JM; Brooks L; O'Nions J; Allday MJ
    Oncogene; 2000 Jul; 19(30):3439-44. PubMed ID: 10918601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome.
    Chua DT; Sham JS; Kwong DL; Tai KS; Wu PM; Lo M; Yung A; Choy D; Leong L
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):711-9. PubMed ID: 9336154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P53 overexpression in nasopharyngeal carcinoma.
    Agaoglu FY; Dizdar Y; Dogan O; Alatli C; Ayan I; Savci N; Tas S; Dalay N; Altun M
    In Vivo; 2004; 18(5):555-60. PubMed ID: 15523893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of main heat stress proteins and p53 in nasopharyngeal carcinoma].
    Cheng L; Liu L; Zhang M; Xiao C; Wu T
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Aug; 17(8):458-60. PubMed ID: 14577255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p53 in recurrent nodal metastasis from nasopharyngeal carcinoma (NPC).
    Chow LW; Khoo US; Yuen AP; Wei WI
    Eur J Surg Oncol; 1997 Oct; 23(5):415-8. PubMed ID: 9393569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidimensional measurement of nasopharyngeal carcinoma: a simple method to predict outcomes.
    Lee CC; Ho HC; Su YC; Lee MS; Hsiao SH; Hwang JH; Hung SK; Chou P; Lee CC
    Clin Otolaryngol; 2009 Feb; 34(1):26-33. PubMed ID: 19260882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma.
    Zhang Y; Li WF; Mao YP; Zhou GQ; Peng H; Sun Y; Liu Q; Chen L; Ma J
    Oncotarget; 2016 Mar; 7(12):13612-20. PubMed ID: 26871291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.